{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:05:29Z","timestamp":1790874329278,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.clim.2013.10.005","type":"journal-article","created":{"date-parts":[[2013,10,12]],"date-time":"2013-10-12T12:45:25Z","timestamp":1381581925000},"page":"121-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cyclization enhances function of linear anti-arthritic peptides"],"prefix":"10.1016","volume":"150","author":[{"given":"Marina","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Amon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Bender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bolte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Separovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Benson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Manolios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2013.10.005_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2009.12.004","article-title":"Antimicrobial peptides: general overview and clinical implications in human health and disease","volume":"135","author":"Guan\u00ed-Guerra","year":"2010","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2013.10.005_bb0010","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.clim.2012.05.010","article-title":"Immune modulating peptides for the treatment and suppression of multiple sclerosis","volume":"144","author":"Badawi","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2013.10.005_bb0015","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1034\/j.1399-3011.2001.00922.x","article-title":"Development of a synthetic cyclized peptide derived from \u03b1-fetoprotein that prevents the growth of human breast cancer","volume":"58","author":"Mesfin","year":"2001","journal-title":"J. Pept. Res."},{"key":"10.1016\/j.clim.2013.10.005_bb0020","first-page":"299","article-title":"Controversial early history of cyclosporin","volume":"131","author":"Heusler","year":"2001","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.clim.2013.10.005_bb0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1021\/ja953070s","article-title":"Self-assembling peptide nanotubes","volume":"118","author":"Hartgerink","year":"1996","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.clim.2013.10.005_bb0030","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/35086601","article-title":"Antibacterial agents based on the cyclic d, l-alpha-peptide architecture","volume":"412","author":"Fernandez-Lopez","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.clim.2013.10.005_bb0035","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1002\/chem.200601583","article-title":"A combinatorial approach to the discovery of biocidal six-residue cyclic D, L-\u03b1-peptides against the bacteria methicillin-resistant Staphylococcus aureus (MRSA) and E. coli and the biofouling algae Ulva linza and Navicula perminuta","volume":"13","author":"Fletcher","year":"2007","journal-title":"Chem. Eur. J."},{"key":"10.1016\/j.clim.2013.10.005_bb0165","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev.immunol.21.120601.141011","article-title":"IgA Fc receptors","volume":"21","author":"Monteiro","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2013.10.005_bb0045","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1039\/b902455g","article-title":"L-\u03b1-glycopeptides","volume":"25","author":"Motiei","year":"2009","journal-title":"Chem. Commun. (Camb.)"},{"key":"10.1016\/j.clim.2013.10.005_bb0050","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nm0197-84","article-title":"T-cell antigen receptor transmembrane peptides modulate T-cell function and T-cell mediated disease","volume":"3","author":"Manolios","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2013.10.005_bb0055","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-3083.2006.01806.x","article-title":"Discrepancy in CD3-transmembrane peptide activity between in vitro and in vivo T-cell inhibition","volume":"64","author":"Collier","year":"2006","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.clim.2013.10.005_bb0060","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1479-8077.2007.00289.x","article-title":"The mode of anti-arthritic peptide delivery impacts on the severity and outcome of adjuvant induced arthritis","volume":"10","author":"Kurosaka","year":"2007","journal-title":"APLAR J. Rheumatol."},{"key":"10.1016\/j.clim.2013.10.005_bb0170","doi-asserted-by":"crossref","first-page":"8969","DOI":"10.1074\/jbc.M709762200","article-title":"Substrate specificity of platypus venom L-to-D-peptide isomerase","volume":"283","author":"Bansal","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2013.10.005_bb0075","doi-asserted-by":"crossref","first-page":"8804","DOI":"10.1021\/jo0484732","article-title":"Pseudo-prolines as removable turn inducers: tools for the cyclisation of small peptides","volume":"69","author":"Skropeta","year":"2004","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.clim.2013.10.005_bb0080","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0009-2614(76)80392-2","volume":"42","author":"Davis","year":"1976","journal-title":"Chem. Phys. Lett."},{"key":"10.1016\/j.clim.2013.10.005_bb0085","doi-asserted-by":"crossref","first-page":"54002","DOI":"10.1074\/jbc.M403909200","article-title":"T-cell antigen receptor peptide \u2014 lipid membrane interactions using surface plasmon resonance","volume":"279","author":"Bender","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2013.10.005_bb0090","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0304-4157(78)90001-1","volume":"515","author":"Seelig","year":"1978","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.clim.2013.10.005_bb0095","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0006-3495(92)81623-5","article-title":"Melittin induced changes in lipid multilayers: a solid-state NMR study","volume":"63","author":"Smith","year":"1992","journal-title":"Biophys. J."},{"key":"10.1016\/j.clim.2013.10.005_bb0100","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1006\/jmbi.1994.1520","article-title":"Structure and orientation of the pore-forming peptide, melittin, in lipid bilayers","volume":"241","author":"Smith","year":"1994","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.clim.2013.10.005_bb0105","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.bbamcr.2006.04.013","article-title":"Lipidation and glycosylation of a T-cell antigen receptor (TCR) transmembrane hydrophobic peptide dramatically enhances in vitro and in vivo function","volume":"1763","author":"Amon","year":"2006","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.clim.2013.10.005_bb0175","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1034\/j.1399-3011.1999.00052.x","article-title":"Solution stability of linear vs. cyclic RGD peptides","volume":"53","author":"Bogdanowich-Knipp","year":"1999","journal-title":"J. Pept. Res."},{"key":"10.1016\/j.clim.2013.10.005_bb0115","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.2174\/092986706777935113","article-title":"Round and round we go: cyclic peptides in disease","volume":"13","author":"Katsara","year":"2006","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.clim.2013.10.005_bb0120","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1006\/bbrc.1996.1045","article-title":"Synthetic peptides derived from the fourth domain of CD4 antagonize off function and inhibit T cell activation","volume":"224","author":"Satoh","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.clim.2013.10.005_bb0125","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1016\/S0960-894X(03)00476-1","article-title":"Improvement of biological activity and proteolytic stability of peptides by coupling with a cyclic peptide","volume":"13","author":"Shibata","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.clim.2013.10.005_bb0130","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0960-894X(00)00140-2","article-title":"Design, synthesis, and biological activity of a cyclic peptide: an inhibitor of HIV-1 Tat\u00b1TAR interactions in human cells","volume":"10","author":"Tamilarasu","year":"2000","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.clim.2013.10.005_bb0135","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.chembiol.2004.03.013","article-title":"Targeting specific PDZ domains of PSD-95; structural basis for enhanced affinity and enzymatic stability of a cyclic peptide","volume":"11","author":"Piserchio","year":"2004","journal-title":"Chem. Biol."},{"key":"10.1016\/j.clim.2013.10.005_bb0140","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1006\/jmbi.2001.5135","article-title":"Cross-reactive binding of cyclic peptides to an anti-TGFalpha antibody Fab fragment: an X-ray structural and thermodynamic analysis","volume":"314","author":"Hahn","year":"2001","journal-title":"Mol. Biol."},{"key":"10.1016\/j.clim.2013.10.005_bb0145","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/366324a0","article-title":"Self-assembling organic nanotubes based on a cyclic peptide architecture","volume":"366","author":"Ghadiri","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.clim.2013.10.005_bb0150","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/sj.gt.3301183","article-title":"Therapeutic application of T cell receptor mimic peptides or cDNA in the treatment of T cell-mediated skin diseases","volume":"7","author":"Gollner","year":"2000","journal-title":"Gene Ther."},{"key":"10.1016\/j.clim.2013.10.005_bb0155","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/bip.21476","article-title":"Cyclic peptides as potential therapeutic agents for skin disorders","volume":"94","author":"Namjoshi","year":"2010","journal-title":"Biopolymers"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661613002635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661613002635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T19:41:36Z","timestamp":1646768496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661613002635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S1521661613002635"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2013.10.005","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cyclization enhances function of linear anti-arthritic peptides","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2013.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}